Levels of prostaglandin E2 and Cysteinyl-leukotrienes in sputum supernatant of patients with asthma: The effect of smoking

Clinical and Experimental Allergy

Volumn 43, Issue 6, 2013, Pages 616-624

  Kontogianni, K ^a   Bakakos, P ^a   Kostikas, K ^a   Hillas, G ^b   Papaporfyriou, A ^a   Papiris, S ^a   Koulouris, N G ^a   Loukides, S ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

Asthma; Inflammation; Smoking eicosanoids

Indexed keywords

METHACHOLINE; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN E2;

ADULT; ARTICLE; ASTHMA; CELL COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SMOKING HABIT; SPUTUM; SPUTUM ANALYSIS; SUPERNATANT;

ADULT; ASTHMA; BRONCHIAL HYPERREACTIVITY; CYSTEINE; DINOPROSTONE; FEMALE; HUMANS; INFLAMMATION; LEUKOTRIENES; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING; SPUTUM;

EID: 84878349103     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12077     Document Type: Article

References (36)

1. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 2009; 15:39-45.
2. Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120:1917-22.
3. Boulet LP, Lemiere C, Archambault F, Carrier G, Descary MC, Deschesnes F. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest 2006; 129:661-8.
4. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003; 111:S18-34; discussion S34-6.
5. Lazarus SC, Chinchilli VM, Rollings NJ et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007; 175:783-90.
6. Gauvreau GM, Watson RM, O'Byrne PM. Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1999; 159:31-6.
7. Chen Y, Chen P, Hanaoka M, Droma Y, Kubo K. Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 2008; 13:1014-21.
8. Aggarwal S, Moodley YP, Thompson PJ, Misso NL. Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation. Clin Exp Allergy 2010; 40:85-93.
9. Profita M, Sala A, Bonanno A et al. Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J Allergy Clin Immunol 2003; 112:709-16.
10. Delimpoura V, Bakakos P, Tseliou E et al. Increased levels of osteopontin in sputum supernatant in severe refractory asthma. Thorax 2010; 65:782-6.
11. Rabinovitch N, Strand M, Stuhlman K, Gelfand EW. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. J Allergy Clin Immunol 2008; 121:1365-71.
12. Gaki E, Papatheodorou G, Ischaki E, Grammenou V, Papa I, Loukides S. Leukotriene E(4) in urine in patients with asthma and COPD-the effect of smoking habit. Respir Med 2007; 101:826-32.
13. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Prostaglandin E2 in the expired breath condensate of patients with asthma. Eur Respir J 2003; 22:743-7.
14. Duffield-Lillico AJ, Boyle JO, Zhou XK et al. Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res (Phila) 2009; 2:322-9.
15. Bateman ED, Hurd SS, Barnes PJ et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-78.
16. Higashi N, Taniguchi M, Mita H, Ishii T, Akiyama K. Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis. Allergy 2003; 58:476-80.
17. Higashi N, Taniguchi M, Mita H et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2004; 113:277-83.
18. Gaber F, Daham K, Higashi A et al. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma. Thorax 2008; 63:1076-82.
19. Kips JC, Fahy JV, Hargreave FE, Ind PW, in't Veen JC. Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur Respir J Suppl 1998; 26:9S-12S.
20. Grootendorst DC, van den Bos JW, Romeijn JJ et al. Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity. Eur Respir J 1999; 13:647-53.
21. Efthimiadis A, Spanevello A, Hamid Q et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl 2002; 37:19s-23s.
22. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995; 152:1107-36.
23. Crapo RO, Casaburi R, Coates AL et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161:309-29.
24. Shin VY, Jin HC, Ng EK, Sung JJ, Chu KM, Cho CH. Activation of 5-lipoxygenase is required for nicotine mediated epithelial-mesenchymal transition and tumor cell growth. Cancer Lett 2010; 292:237-45.
25. Figueroa DJ, Breyer RM, Defoe SK et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001; 163:226-33.
26. Hemelaers L, Henket M, Sele J, Bureau F, Louis R. Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthmatics. Allergy 2006; 61:136-9.
27. Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127:1553-9.
28. Clearie KL, McKinlay L, Williamson PA, Lipworth BJ. Fluticasone/Salmeterol combination confers benefits in people with asthma who smoke. Chest 2012; 141:330-8.
29. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000; 69:145-82.
30. Zhao WW, Robinson NE, Yu MF. PGE2 inhibits acetylcholine release from cholinergic nerves in canine but not equine airways. Prostaglandins Leukot Essent Fatty Acids 1994; 51:347-55.
31. Pavord ID, Wisniewski A, Mathur R, Wahedna I, Knox AJ, Tattersfield AE. Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. Thorax 1991; 46:633-7.
32. Sturm EM, Schratl P, Schuligoi R et al. Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors. J Immunol 2008; 181:7273-83.
33. Huang RY, Chen GG. Cigarette smoking, cyclooxygenase-2 pathway and cancer. Biochim Biophys Acta 2011;1815: 158-69.
34. Mai XM, Bottcher MF, Bruhammar M, Nilsson L, Zetterstrom O. Urinary inflammatory mediators and inhalation of hypertonic saline in children. Allergy 2005; 60:60-4.
35. Hjoberg J, Folkerts G, van Gessel SB, Hogman M, Hedenstierna G, Nijkamp FP. Hyperosmolarity-induced relaxation and prostaglandin release in guinea pig trachea in vitro. Eur J Pharmacol 2000; 398:303-7.
36. Giouleka P, Papatheodorou G, Lyberopoulos P et al. Body mass index is associated with leukotriene inflammation in asthmatics. Eur J Clin Invest 2011; 41:30-8.